5 Results for "

PD-L1-PROTAC degrader

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "PD-L1-PROTAC degrader" in MCE Product Catalog:

Cat. No.: HY-163757
CAS No.: 3052114-77-6
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PROTAC PD-L1 degrader-1 is a CRBN-based PD-L1-PROTAC degrader with a notable PD-L1 protein degradation capability. PROTAC PD-L1 degrader-1 shows potent PD-L1 degradation in 4T1 cells with a DC50 of 0.609 μM. PROTAC PD-L1 degrader-1 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-131183
CAS No.: 2447066-37-5
Purity:  99.52%
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology

PROTAC PD-1/PD-L1 degrader-1, a PD-1/PD-L1 PROTAC based on Cereblon E3 ligand, inhibits PD-1/PD-L1 interaction with an IC50 of 39.2 nM. PROTAC PD-1/PD-L1 degrader-1 significantly restores the immunity repressed in a co-culture model of Hep3B/OS-8/hPD-L1 and CD3 T cells. PROTAC PD-1/PD-L1 degrader-1 moderately reduces the protein levels of PD-L1 in a lysosome-dependent manner .
loading...
    loading...
Cat. No.: HY-162972
CAS No.: 2995357-09-8
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PROTAC PD-L1 degrader-2 is a PD-L1 PROTAC degrader with an IC50 of 197.4 nM and a Kd of 301 nM. PROTAC PD-L1 degrader-2 induces PD-L1 endocytosis, drives degradation via the proteasomal and lysosomal pathways, and inhibits the PD-1/PD-L1 interaction. As an immune activator, PROTAC PD-L1 degrader-2 increases the levels of CD4 +, CD8 +, granzyme B and perforin. PROTAC PD-L1 degrader-2 can be used in studies related to colon cancer immunology .
loading...
    loading...
Cat. No.: HY-179304
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Cancer

CL-F-B1 is a PD-L1 PROTAC degrader, with a DC50 of 2.32 μM. CL-F-B1 promotes the ubiquitination and degradation of PD-L1. CL-F-B1 can be used in the research of colon cancer .
loading...
    loading...
Cat. No.: HY-179306
CAS No.: 2983442-53-9
Research Areas:  

Cancer

trans-Thalidomide-1,4-cyclohexanediamine is a PROTAC E3 ligase-linker conjugate that can be used for synthesis of PROTACs, such as CL-F-B1 (HY-179304). CL-F-B1 is a potent PD-L1 PROTAC degrader with anticancer activity .
loading...
    loading...